Fresenius Medical Care AG KGaA Long Term Debt 2012-2026 | FMS
Fresenius Medical Care AG KGaA long term debt from 2012 to 2026. Long term debt can be defined as the sum of all long term debt fields.
- Fresenius Medical Care AG KGaA long term debt for the quarter ending March 31, 2026 was $6.720B, a 3.73% increase year-over-year.
- Fresenius Medical Care AG KGaA long term debt for 2025 was $6.44B, a 4.95% decline from 2024.
- Fresenius Medical Care AG KGaA long term debt for 2024 was $6.775B, a 10.06% decline from 2023.
- Fresenius Medical Care AG KGaA long term debt for 2023 was $7.533B, a 0.3% decline from 2022.
|
Fresenius Medical Care AG KGaA Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2025 | $6,440 |
| 2024 | $6,775 |
| 2023 | $7,533 |
| 2022 | $7,555 |
| 2021 | $7,864 |
| 2020 | $7,768 |
| 2019 | $7,233 |
| 2018 | $5,959 |
| 2017 | $6,550 |
| 2016 | $7,203 |
| 2015 | $7,853 |
| 2014 | $9,014 |
| 2013 | $7,747 |
| 2012 | $7,842 |
| 2011 | $5,495 |
|
Fresenius Medical Care AG KGaA Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2026-03-31 | $6,720 |
| 2025-12-31 | $6,440 |
| 2025-09-30 | $7,391 |
| 2025-06-30 | $7,182 |
| 2025-03-31 | $6,478 |
| 2024-12-31 | $6,775 |
| 2024-09-30 | $6,855 |
| 2024-06-30 | $7,381 |
| 2024-03-31 | $7,618 |
| 2023-12-31 | $7,533 |
| 2023-09-30 | $7,907 |
| 2023-06-30 | $7,630 |
| 2023-03-31 | $7,865 |
| 2022-12-31 | $7,555 |
| 2022-09-30 | $8,127 |
| 2022-06-30 | $7,730 |
| 2022-03-31 | $8,362 |
| 2021-12-31 | $7,864 |
| 2021-09-30 | $7,749 |
| 2021-06-30 | $7,831 |
| 2021-03-31 | $7,614 |
| 2020-12-31 | $7,768 |
| 2020-09-30 | $8,159 |
| 2020-06-30 | $6,908 |
| 2020-03-31 | $6,402 |
| 2019-12-31 | $7,233 |
| 2019-09-30 | $6,767 |
| 2019-06-30 | $4,283 |
| 2019-03-31 | $6,453 |
| 2018-12-31 | $5,959 |
| 2018-09-30 | $5,861 |
| 2018-06-30 | $6,547 |
| 2018-03-31 | $7,126 |
| 2017-12-31 | $6,550 |
| 2017-09-30 | $6,855 |
| 2017-06-30 | $7,027 |
| 2017-03-31 | $7,182 |
| 2016-12-31 | $7,203 |
| 2016-09-30 | $7,174 |
| 2016-06-30 | $7,702 |
| 2016-03-31 | $7,847 |
| 2015-12-31 | $7,853 |
| 2015-09-30 | $8,351 |
| 2015-06-30 | $8,798 |
| 2015-03-31 | $8,602 |
| 2014-12-31 | $9,014 |
| 2014-09-30 | $7,713 |
| 2014-06-30 | $8,444 |
| 2014-03-31 | $8,016 |
| 2013-12-31 | $7,747 |
| 2013-09-30 | $7,772 |
| 2013-06-30 | $7,657 |
| 2013-03-31 | $7,361 |
| 2012-12-31 | $7,842 |
| 2012-09-30 | $7,734 |
| 2012-06-30 | $5,543 |
| 2012-03-31 | $5,583 |
| 2011-12-31 | $5,495 |
| 2011-09-30 | $5,487 |
| 2011-06-30 | $5,960 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $13.199B | $22.202B |
| Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products.. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.365B | 21.69 |
| Intuitive Surgical (ISRG) | United States | $160.029B | 61.73 |
| Edwards Lifesciences (EW) | United States | $44.895B | 30.42 |
| IDEXX Laboratories (IDXX) | United States | $44.716B | 43.08 |
| Alcon (ALC) | Switzerland | $38.585B | 25.49 |
| Waters (WAT) | United States | $31.413B | 24.37 |
| IQVIA Holdings (IQV) | United States | $28.398B | 15.40 |
| Mettler-Toledo (MTD) | United States | $26.829B | 30.97 |
| DexCom (DXCM) | United States | $24.639B | 30.63 |
| STERIS (STE) | Ireland | $21.830B | 22.08 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| Coloplast (CLPBY) | Denmark | $15.055B | 23.03 |
| SONOVA HOLDING (SONVY) | Switzerland | $13.774B | 0.00 |
| Penumbra (PEN) | United States | $12.941B | 85.88 |
| Globus Medical (GMED) | United States | $12.230B | 22.60 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| Glaukos (GKOS) | United States | $6.760B | 0.00 |
| SARTORIUS (SSSGY) | Germany | $6.754B | 39.22 |
| Sysmex ADR (SSMXY) | Japan | $5.470B | 18.10 |
| Teleflex (TFX) | United States | $5.233B | 9.67 |
| TransMedics (TMDX) | United States | $3.910B | 40.00 |
| LivaNova (LIVN) | United Kingdom | $3.433B | 18.41 |
| Integer Holdings (ITGR) | United States | $2.900B | 13.28 |
| Veracyte (VCYT) | United States | $2.470B | 24.48 |
| Elekta AB (EKTAY) | Sweden | $2.226B | 20.13 |
| Artivion (AORT) | United States | $1.825B | 59.73 |
| AxoGen (AXGN) | United States | $1.659B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.650B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.642B | 18.12 |
| UFP Technologies (UFPT) | United States | $1.552B | 20.54 |
| Tandem Diabetes Care (TNDM) | United States | $1.314B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.308B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.269B | 0.00 |
| IRadimed (IRMD) | United States | $1.194B | 53.37 |
| OPKO Health (OPK) | United States | $0.881B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.772B | 4.44 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.659B | 15.09 |
| Alpha Tau Medical (DRTS) | Israel | $0.618B | 0.00 |
| SiBone (SIBN) | United States | $0.567B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.552B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.533B | 28.23 |
| Mesa Laboratories (MLAB) | United States | $0.530B | 13.79 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.497B | 0.00 |
| NeuroPace (NPCE) | United States | $0.480B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.405B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.405B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.404B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.393B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.346B | 143.43 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.296B | 0.00 |
| RxSight (RXST) | United States | $0.282B | 0.00 |
| 908 Devices (MASS) | United States | $0.267B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.257B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.203B | 0.00 |
| CVRx (CVRX) | United States | $0.188B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.186B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.172B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.148B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Hyperfine (HYPR) | United States | $0.119B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.117B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.111B | 0.00 |
| Solana (HSDT) | United States | $0.104B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.096B | 0.00 |
| Neuronetics (STIM) | United States | $0.094B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.083B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 0.00 |
| LENSAR (LNSR) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | United States | $0.060B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| DarioHealth (DRIO) | United States | $0.053B | 0.00 |
| Envoy Medical (COCH) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.047B | 0.00 | |
| Accuray (ARAY) | United States | $0.046B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.028B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| NexGel (NXGL) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |